The Respimat® Development Story: Patient-Centered Innovation-Reference-Cited by-同舟云学术

The Respimat® Development Story: Patient-Centered Innovation

Published:2017-04-06 Issue:1 Volume:3 Page:19-30
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Wachtel Herbert,Kattenbeck Sabine,Dunne Stephen,Disse Bernd

Funder

Boehringer Ingelheim

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Respiratory Care

Link

http://link.springer.com/content/pdf/10.1007/s41030-017-0040-8.pdf

Reference58 articles.

1. Ari A, Fink JB. Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy. Expert Rev Respir Med. 2011;5(4):561–72.

2. Islam N, Cleary MJ. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery—a review for multidisciplinary researchers. Med Eng Phys. 2012;34(4):409–27.

3. Anderson P. Use of Respimat Soft Mist inhaler in COPD patients. Int J Chron Obstruct Pulmon Dis. 2006;1(3):251–9.

4. Dalby R, Spallek M, Voshaar T. A review of the development of Respimat Soft Mist Inhaler. Int J Pharm. 2004;283(1–2):1–9.

5. Dalby RN, Eicher J, Zierenberg B. Development of Respimat® Soft Mist Inhaler and its clinical utility in respiratory disorders. Med Devices (Auckl). 2011;4:145–55.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geriatric drug delivery ― barriers, current technologies and the road ahead;Journal of Drug Targeting;2024-08-09

2. Effect of airflow rate on droplet deposition of an impinging-jet inhaler in the human respiratory tract;International Journal of Pharmaceutics;2024-08

3. Nanomedicines via the pulmonary route: a promising strategy to reach the target?;Drug Delivery and Translational Research;2024-04-08

4. Aerosol Plumes of Inhalers Used in COPD;Pulmonary Therapy;2024-01-09

5. Lung Microbiota: Its Relationship to Respiratory System Diseases and Approaches for Lung-Targeted Probiotic Bacteria Delivery;Molecular Pharmaceutics;2023-06-21